1 terminated. 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 1 | Terminated 1 |
Follow Hugh McMillan: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Effect of Low-Dose Celecoxib on SMN2 in Patients With Spinal Muscular Atrophy celecoxib - Spinal Muscular Atrophy (SMA) | Phase 2 | Terminated | Hugh McMillan | 1 | 2019-01-29 | 2020-10-19 |
Celecoxib (1)
Canada (1)